Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis.
Shuyan GuLizheng ShiHui ShaoXiaoyong WangXiaoqian HuYuxuan GuHengjin DongPublished in: BMC medicine (2020)
This study provides evidence-based references for diabetes management. Our findings can be used to design the essential drug formulary, infer clinical practice, and help the decision-maker design reimbursement policy.